 associated
with risk of hyperperfusion syndrome and intracranial
hemorrhage after CAS procedures.61 Post-CAS hypertension and hypotension are both associated with increased
risk of periprocedural stroke and mortality. In an analysis
of 5263 patients who underwent CAS in the Vascular
Quality Initiative (VQI), beta blocker use for more than
30 days decreased the stroke/death rates after CAS,
although the beneÔ¨Åt may not